- Last edited on December 29, 2021
Differences
This shows you the differences between two versions of the page.
cl:multiple-sclerosis [on September 16, 2018] |
cl:multiple-sclerosis [on April 25, 2020] |
||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Multiple Sclerosis (MS) ====== | ||
+ | {{INLINETOC}} | ||
+ | ===== Primer ===== | ||
+ | **Multiple Sclerosis** (MS) is a chronic inflammatory disease of the central nervous system. | ||
+ | ==== Prevalence ==== | ||
+ | MS affects more than 2 million people worldwide. | ||
+ | |||
+ | ===== Neuropsychiatric Symptoms ===== | ||
+ | MS patients have a 50% chance of developing depression. Depression in MS patients not like typical MDD - there is usually less neurovegetative symptoms. If there is a family history of MDD, there is an 80% chance of developing depression in MS. | ||
+ | |||
+ | ===== Resources ===== | ||
+ | * [[https://www.nejm.org/doi/full/10.1056/NEJMra1401483|Review Article - Longo, D. L. (2018). Multiple Sclerosis. N Engl J Med, 378, 169-80.]] |